Aravive Announces Participation at Wedbush PacGrow Healthcare Conference

NEXT STORY
Generex Biotechnology Announces Interview with President & CEO Joe Moscato
PREV STORY
Ziopharm Oncology Reports Second Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Talaris Therapeutics Announces Initiation of Phase 2 Clinical Trial of FCR001 in Delayed Tolerance Induction

author_avatar
NASDAQ Market News

Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone

author_avatar
NASDAQ Market News

Global $39.96 Billion Pulmonary Devices Market to 2027: Consumables and Accessories to Grow at the Highest Rate

author_avatar
NASDAQ Market News